Clostridium butyricum

Overview

Clostridium butyricum is a butyrate-producing, spore-forming bacterium that lives naturally in soil and in the healthy human and animal gut. Although the genus Clostridium also contains some well-known pathogens, the specific food-grade strains used in supplements are non-toxigenic and are classified as probiotics. The best known is strain MIYAIRI 588 (also sold as CBM 588 or under the product name Miya-BM), which has been used as a probiotic for digestive health for many decades.

History and Traditional Use

The MIYAIRI 588 strain was isolated in Japan in the 1930s by the physician Chikaji Miyairi, who was studying bacteria that could help stabilize the gut. The strain has since been used widely in Japan and other parts of Asia as a probiotic for digestive complaints, and it remains a long-standing example of a butyrate-producing probiotic supplement.

Active Properties and Mechanisms

The defining feature of C. butyricum is its production of butyrate, a short-chain fatty acid, through fermentation of dietary fiber and other carbohydrates in the colon. Butyrate is a primary energy source for the cells lining the colon and is involved in maintaining the integrity of the intestinal barrier and in modulating the local immune environment. As a probiotic, C. butyricum is also reported to influence the balance of the gut microbiota, including supporting beneficial bacteria such as bifidobacteria. Because it forms spores, it is relatively resistant to stomach acid and heat, which helps it survive passage to the intestine.

Areas of Use and Evidence

Research on C. butyricum probiotics has focused mainly on digestive health. Reported areas of study include prevention of antibiotic-associated diarrhea, support during and after antibiotic treatment, and symptom management in functional gut disorders such as irritable bowel syndrome. It has also been studied as an adjunct in other gastrointestinal conditions. The overall body of evidence is still developing and varies in quality by indication, so its effects are best described as promising in specific digestive contexts rather than firmly established across the board.

Associated Body Systems

The supplement is associated primarily with the digestive system and the gut microbiome. Through butyrate production and effects on the intestinal lining and local immunity, it is also discussed in relation to general gut-barrier and immune support.

Forms and Use

It is sold as a probiotic supplement in capsules, tablets, and powders, typically standardized to a number of viable spores or colony-forming units per dose. It is sometimes combined with other probiotic species or with prebiotic fibers. Specific dosages vary by product and by the studies in which the strain has been examined.

Safety

The food-grade probiotic strains of C. butyricum, such as MIYAIRI 588, are non-toxigenic and have a long record of use as supplements with a generally favorable safety profile in healthy people. As with other live probiotics, caution is generally advised for people who are severely immunocompromised, critically ill, or who have central venous catheters, and such individuals should seek individualized medical guidance before using probiotic products.